IL166434A0 - Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase - Google Patents

Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase

Info

Publication number
IL166434A0
IL166434A0 IL16643405A IL16643405A IL166434A0 IL 166434 A0 IL166434 A0 IL 166434A0 IL 16643405 A IL16643405 A IL 16643405A IL 16643405 A IL16643405 A IL 16643405A IL 166434 A0 IL166434 A0 IL 166434A0
Authority
IL
Israel
Prior art keywords
rhein
rise
rate
therapeutic treatment
heme oxygenase
Prior art date
Application number
IL16643405A
Other languages
English (en)
Original Assignee
Negma Lerads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Lerads filed Critical Negma Lerads
Publication of IL166434A0 publication Critical patent/IL166434A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16643405A 2002-07-23 2005-01-20 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase IL166434A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0209340A FR2842738B1 (fr) 2002-07-23 2002-07-23 Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
PCT/FR2003/002286 WO2004010990A1 (fr) 2002-07-23 2003-07-18 Elevation du taux d’ heme oxygenase avec des derives de la rheine

Publications (1)

Publication Number Publication Date
IL166434A0 true IL166434A0 (en) 2006-01-15

Family

ID=30011416

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16643405A IL166434A0 (en) 2002-07-23 2005-01-20 Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase

Country Status (9)

Country Link
US (1) US20060058392A1 (de)
EP (1) EP1523312A1 (de)
JP (1) JP2005538098A (de)
AU (1) AU2003269037A1 (de)
CA (1) CA2493074A1 (de)
FR (1) FR2842738B1 (de)
IL (1) IL166434A0 (de)
MX (1) MXPA05000904A (de)
WO (1) WO2004010990A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
WO2011022617A1 (en) * 2009-08-20 2011-02-24 Anchen Laboratories, Inc. Methods for diagnosing diabetes and determining effectiveness of treatments
US8652540B2 (en) * 2012-06-04 2014-02-18 Hong Kong Baptist University Method of using rhein for treating fibrotic conditions and tumors
TWI743047B (zh) * 2015-08-17 2021-10-21 安成生物科技股份有限公司 使用雙醋瑞因或其類似物抑制asc表現、nlrp3表現、以及/或nlrp3發炎體複合物的形成之方法
TW201739448A (zh) * 2016-05-06 2017-11-16 安成生物科技股份有限公司 用於治療及/或預防血液相關疾病之方法及配方
CA3049450A1 (en) * 2017-01-19 2018-07-26 Twi Biotechnology, Inc. Methods and pharmaceutical compositions for preventing or treating immunoinflammatory dermal disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
JPH0374326A (ja) * 1989-08-17 1991-03-28 Tsumura & Co ケミルミネッセンス抑制剤
CA2132690A1 (en) * 1994-09-22 1996-03-23 Dean Willis Control and modulation of inflammatory response in humans in need of such control and modulation
US5652265A (en) * 1995-03-29 1997-07-29 Wisconsin Alumni Research Foundation Production of rhein and rhein derivatives
IT1283771B1 (it) * 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
CN1216900C (zh) * 1997-04-11 2005-08-31 桑斯塔特医学有限公司 用于调节免疫系统活性和抑制炎症的细胞调节性亲脂肽
CN1086289C (zh) * 1997-09-30 2002-06-19 中国人民解放军肾脏病研究所 大黄酸或大黄酸盐在制备治疗糖尿病肾病药中的用途
DE69941966D1 (de) * 1998-02-13 2010-03-11 Nutramax Lab Inc Mittel und Verfahren zum Schutz, zur Behandlung und Reparatur von Bindegewebe
AU6022999A (en) * 1998-08-28 2000-03-21 Mu-En Lee Inhibiting cardiomyocyte death
JP2000119182A (ja) * 1998-10-09 2000-04-25 Nippon Chemiphar Co Ltd ヘムオキシゲナーゼ誘導促進剤
AR024523A1 (es) * 1998-12-17 2002-10-16 Sangstat Medical Corp Metodo para aumentar la sobrevida de un injerto por modulacion de la actividad de hemo oxigenasa
EP1266660A4 (de) * 2000-03-17 2006-03-22 Toshio Tanaka Heme-oxygenase-1 induktoren oder deren vorbeugung verstärkende mittel
US6610750B1 (en) * 2000-09-15 2003-08-26 Laboratoires Negma Treatment of osteoarthritis
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level

Also Published As

Publication number Publication date
FR2842738B1 (fr) 2006-02-10
FR2842738A1 (fr) 2004-01-30
JP2005538098A (ja) 2005-12-15
CA2493074A1 (fr) 2004-02-05
EP1523312A1 (de) 2005-04-20
US20060058392A1 (en) 2006-03-16
AU2003269037A1 (en) 2004-02-16
MXPA05000904A (es) 2005-03-23
WO2004010990A1 (fr) 2004-02-05

Similar Documents

Publication Publication Date Title
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
GB0206033D0 (en) Compounds useful in therapy
IL172316A0 (en) Novel compounds and their use in therapy
GB0316912D0 (en) Therapeutic treatment
GB0324761D0 (en) Use of compounds in therapy
GB0320806D0 (en) Therapeutic treatment
HK1078784A1 (en) Therapeutic treatment
IL166434A0 (en) Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase
GB0223367D0 (en) Therapeutic treatment
GB0219660D0 (en) Therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
GB0210464D0 (en) Therapeutic treatment
GB0329275D0 (en) Therapeutic treatment
AU2003296545A8 (en) Use of a trpm8-activating substance for the treatment of tumours
GB0307863D0 (en) Therapeutic treatment
GB0313772D0 (en) Therapeutic treatment
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB2392839A8 (en) Use of Mycobacterium w in the treatment of tubercolosis
GB0225688D0 (en) Therapeutic compounds and their use in therapy
SI1553950T1 (sl) Terapevtsko zdravljenje
GB0223118D0 (en) Therapeutic use
GB0224787D0 (en) Therapeutic use
GB0226850D0 (en) Therapeutic use